1. Home
  2. SOL vs IMUX Comparison

SOL vs IMUX Comparison

Compare SOL & IMUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SOL
  • IMUX
  • Stock Information
  • Founded
  • SOL 2005
  • IMUX 2016
  • Country
  • SOL United States
  • IMUX United States
  • Employees
  • SOL N/A
  • IMUX N/A
  • Industry
  • SOL Semiconductors
  • IMUX Biotechnology: Pharmaceutical Preparations
  • Sector
  • SOL Technology
  • IMUX Health Care
  • Exchange
  • SOL Nasdaq
  • IMUX Nasdaq
  • Market Cap
  • SOL 84.6M
  • IMUX 90.3M
  • IPO Year
  • SOL 2008
  • IMUX N/A
  • Fundamental
  • Price
  • SOL $1.26
  • IMUX $0.98
  • Analyst Decision
  • SOL Buy
  • IMUX Strong Buy
  • Analyst Count
  • SOL 3
  • IMUX 6
  • Target Price
  • SOL $3.50
  • IMUX $13.20
  • AVG Volume (30 Days)
  • SOL 218.6K
  • IMUX 661.4K
  • Earning Date
  • SOL 05-22-2025
  • IMUX 05-07-2025
  • Dividend Yield
  • SOL N/A
  • IMUX N/A
  • EPS Growth
  • SOL N/A
  • IMUX N/A
  • EPS
  • SOL N/A
  • IMUX N/A
  • Revenue
  • SOL $92,067,000.00
  • IMUX N/A
  • Revenue This Year
  • SOL N/A
  • IMUX N/A
  • Revenue Next Year
  • SOL $45.37
  • IMUX N/A
  • P/E Ratio
  • SOL N/A
  • IMUX N/A
  • Revenue Growth
  • SOL N/A
  • IMUX N/A
  • 52 Week Low
  • SOL $1.04
  • IMUX $0.83
  • 52 Week High
  • SOL $3.00
  • IMUX $2.11
  • Technical
  • Relative Strength Index (RSI)
  • SOL 38.04
  • IMUX 45.24
  • Support Level
  • SOL $1.16
  • IMUX $0.86
  • Resistance Level
  • SOL $1.46
  • IMUX $1.01
  • Average True Range (ATR)
  • SOL 0.11
  • IMUX 0.09
  • MACD
  • SOL -0.03
  • IMUX -0.01
  • Stochastic Oscillator
  • SOL 20.00
  • IMUX 42.53

About SOL Emeren Group Ltd each representing 10 shares

Emeren Group Ltd is a renewable energy producer. Its portfolio consists of solar projects and Independent Power Producer (IPP) assets, and it also has global Battery Energy Storage System (BESS) capacity. The group specializes in the solar project lifecycle, development, and from construction to financing. It has three reportable segments; Solar power project development, EPC services, and Electricity generation. The company generates maximum revenue from Poland.

About IMUX Immunic Inc.

Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.

Share on Social Networks: